Active Shortage Insert Ophthalmology
Hydroxypropyl Cellulose Inse · 2,324 days since initial FDA posting
Brand: LACRISERT
FDA lists Hydroxypropyl Cellulose Inse as Active Shortage (Bausch & Lomb Incorporated).
Availability on file: Unavailable
Hydroxypropyl Cellulose (1600000 Wamw) Insert: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydroxypropyl Cellulose (1600000 Wamw) Insert
- Manufacturer
- Bausch & Lomb Incorporated
- Dosage Form
- Insert
- Presentation
- Lacrisert, Insert, 5 mg (NDC 24208-800-60)
- Package NDC
- 24208-800-60
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- May 1, 2020
- Last Updated
- Nov 17, 2025
- Therapeutic Category
- Ophthalmology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.